➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
McKinsey
Express Scripts
Johnson and Johnson
Merck

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

Baxter Hlthcare Corp Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic and branded alternatives to BAXTER HLTHCARE CORP drugs are available?

BAXTER HLTHCARE CORP has forty-four approved drugs.

There is one tentative approval on BAXTER HLTHCARE CORP drugs.

Summary for Baxter Hlthcare Corp
US Patents:0
Tradenames:56
Ingredients:34
NDAs:44

Drugs and US Patents for Baxter Hlthcare Corp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-013 Oct 10, 2008 DISCN Yes No   Start Trial   Start Trial
Baxter Hlthcare Corp HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 076791-001 Aug 25, 2004 DISCN No No   Start Trial   Start Trial
Baxter Hlthcare Corp PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-014 Oct 10, 2008 RX Yes Yes   Start Trial   Start Trial
Baxter Hlthcare Corp ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 074768-001 Jan 23, 1997 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Baxter Hlthcare Corp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-001 Nov 17, 1995 5,213,804   Start Trial
Baxter Hlthcare Corp CLINOLIPID 20% olive oil; soybean oil EMULSION;INTRAVENOUS 204508-001 Oct 3, 2013 5,840,757   Start Trial
Baxter Hlthcare Corp PRALIDOXIME CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 018799-001 Dec 13, 1982 3,629,425   Start Trial
Baxter Hlthcare Corp DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-002 Jun 13, 2000 5,013,556   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Boehringer Ingelheim
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.